Targeting early events in T cell activation to construct improved vaccines
- 30 June 2000
- journal article
- review article
- Published by Elsevier in Molecular Immunology
- Vol. 37 (9) , 545-552
- https://doi.org/10.1016/s0161-5890(00)00073-0
Abstract
No abstract availableKeywords
Funding Information
- Foundation for Research, Science and Technology
- Marsden Fund
This publication has 51 references indexed in Scilit:
- Anin vivocomparison of bacillus Calmette–Guérin (BCG) and cytokine‐secreting BCG vaccinesImmunology, 1999
- Cytokine adjuvants: lessons from the past—guidelines for the future?Veterinary Immunology and Immunopathology, 1998
- The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cellsEuropean Journal of Immunology, 1997
- Clinical Toxicity of Cytokines Used As Haemopoietic Growth FactorsDrug Safety, 1995
- Cytotoxic T Lymphocyte Responses to a Liposome-Adjuvanted Influenza A Virus Vaccine in the ElderlyThe Journal of Infectious Diseases, 1995
- Cytokines as potential vaccine adjuvantsBiotherapy, 1994
- Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccinesNature, 1991
- Receptor-Mediated Antigen Uptake and its Effect on Antigen Presentation to Class II-Restricted T LymphocytesAnnual Review of Immunology, 1990
- Immunological adjuvants: a role for liposomesImmunology Today, 1990
- Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: Characterization and evidence for receptor recyclingCell, 1980